Concepedia

Douglas Vanderburg

DV

Statistics

Publications

13

Citations

696

H-Index

12

Active since

1978

Affiliations

Pfizer (United States)(Current)

University of Cincinnati Medical Center

Massachusetts General Hospital

University of Toronto

Centre for Addiction and Mental Health

Douglas Vanderburg is an author at Pfizer (United States) specializing in psychopharmacology, psychiatry, and pharmacotherapy.

Publications per year

1978–2013

13

Publications

13

Sertraline Treatment of Children and Adolescents With Posttraumatic Stress Disorder: A Double-Blind, Placebo-Controlled Trial

Adelaide S. Robb, Jeanette E. Cueva, Jonathan Sporn et al. · Journal of Child and Adolescent Psychopharmacology · 2010 · 128 citations

, , +17

Efficacy and Safety of Adjunctive Oral Ziprasidone for Acute Treatment of Depression in Patients With Bipolar I Disorder

Kathleen Ice, Phillip Chappell, Jeffrey H. Schwartz et al. · The Journal of Clinical Psychiatry · 2011 · 102 citations

, , +17

Efficacy, Long-Term Safety, and Tolerability of Ziprasidone in Children and Adolescents with Bipolar Disorder

Robert L. Findling, Idil Çavuş, Elizabeth Pappadopulos et al. · Journal of Child and Adolescent Psychopharmacology · 2013 · 100 citations · Full text

, , +17

Application of weight-height ratios and body indices to juvenile populations—the national health examination survey data

Judith Killeen, Douglas Vanderburg, William R. Harlan · Journal of Chronic Diseases · 1978 · 88 citations

, , +12

Ziprasidone in Adolescents with Schizophrenia: Results from a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Robert L. Findling, Idil Çavuş, Elizabeth Pappadopulos et al. · Journal of Child and Adolescent Psychopharmacology · 2013 · 61 citations · Full text

, , +17

1–5 of 13